
TY  - JOUR
TI  - Abstracts of the Third International Congress. Psoriasis: From Gene to Clinic
JO  - British Journal of Dermatology
VL  - 147
IS  - 5
SN  - 0007-0963
UR  - https://doi.org/10.1046/j.1365-2133.2002.05072.x
DO  - doi:10.1046/j.1365-2133.2002.05072.x
SP  - 1047
EP  - 1078
PY  - 2002
ER  - 

TY  - JOUR
AU  - Boskabady, Mohammad Hossein
AU  - Farkhondeh, Tahereh
C8  - PTR-16-0008.R1
TI  - Antiinflammatory, Antioxidant, and Immunomodulatory Effects of Crocus sativus L. and its Main Constituents
JO  - Phytotherapy Research
JA  - Phytother. Res.
VL  - 30
IS  - 7
SN  - 0951-418X
UR  - https://doi.org/10.1002/ptr.5622
DO  - doi:10.1002/ptr.5622
SP  - 1072
EP  - 1094
KW  - Crocus sativus
KW  - crocins
KW  - crocetin
KW  - safranal
KW  - antiinflammatory
KW  - antioxidant
KW  - immunomodulation
PY  - 2016
AB  - Crocus sativus L. (C.?sativus), commonly known as saffron, is used as a food additive, preservative, and medicinal herb. Traditionally, it has been used as an alternative treatment for different diseases. C.?sativus' medicinal effects are related to its major constituents like crocins, crocetin, and safranal. According to the literature, C.?sativus and its constituents could be considered as an effective treatment for neurodegenerative disorders, coronary artery diseases, asthma, bronchitis, colds, fever, diabetes, and so on. Recently, numerous studies have reported such medicinal properties and found that the underlying mechanisms of action may be mediated by antioxidant, inflammatory, and immunomodulatory effects. C.?sativus enhances the antioxidant capacity and acts as a free radical scavenger. As an antiinflammatory and immunomodulatory agent, it modulates inflammatory mediators, humoral immunity, and cell-mediated immunity responses. This review highlights in vitro and animal findings regarding antiinflammatory, antioxidant, and immunomodulatory effects of C.?sativus and its constituents. Present review found that the C.?sativus and its main constituents such as safranal, crocins, and crocetin could be effective against various diseases because of their antioxidant, anti-inflammation, and immunomodulatory effects. Copyright ? 2016 John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - 2nd Trends in Medical Mycology
JO  - Mycoses
VL  - 48
IS  - s2
SN  - 0933-7407
UR  - https://doi.org/10.1111/j.1439-0507.2005.01157.x
DO  - doi:10.1111/j.1439-0507.2005.01157.x
SP  - 7
EP  - 103
PY  - 2005
ER  - 

TY  - JOUR
AU  - Aucamp, Janine
AU  - Bronkhorst, Abel J.
AU  - Badenhorst, Christoffel P. S.
AU  - Pretorius, Piet J.
TI  - The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature
JO  - Biological Reviews
JA  - Biol Rev
VL  - 93
IS  - 3
SN  - 1464-7931
UR  - https://doi.org/10.1111/brv.12413
DO  - doi:10.1111/brv.12413
SP  - 1649
EP  - 1683
KW  - active DNA release
KW  - cellular breakdown mechanisms
KW  - circulating mitochondrial DNA
KW  - in vitro cell culture
KW  - lateral information transfer
PY  - 2018
AB  - ABSTRACT Since the detection of cell-free DNA (cfDNA) in human plasma in 1948, it has been investigated as a non-invasive screening tool for many diseases, especially solid tumours and foetal genetic abnormalities. However, to date our lack of knowledge regarding the origin and purpose of cfDNA in a physiological environment has limited its use to more obvious diagnostics, neglecting, for example, its potential utility in the identification of predisposition to disease, earlier detection of cancers, and lifestyle-induced epigenetic changes. Moreover, the concept or mechanism of cfDNA could also have potential therapeutic uses such as in immuno- or gene therapy. This review presents an extensive compilation of the putative origins of cfDNA and then contrasts the contributions of cellular breakdown processes with active mechanisms for the release of cfDNA into the extracellular environment. The involvement of cfDNA derived from both cellular breakdown and active release in lateral information transfer is also discussed. We hope to encourage researchers to adopt a more holistic view of cfDNA research, taking into account all the biological pathways in which cfDNA is involved, and to give serious consideration to the integration of in vitro and in vivo research. We also wish to encourage researchers not to limit their focus to the apoptotic or necrotic fraction of cfDNA, but to investigate the intercellular messaging capabilities of the actively released fraction of cfDNA and to study the role of cfDNA in pathogenesis.
ER  - 

TY  - JOUR
TI  - Abstracts from the Tenth International Conference on Pediatric Mechanical Circulatory Support Systems and Pediatric Cardiopulmonary Bypass
JO  - Artificial Organs
JA  - Artificial Organs
VL  - 38
IS  - 5
SN  - 0160-564X
UR  - https://doi.org/10.1111/aor.12324
DO  - doi:10.1111/aor.12324
SP  - A1
EP  - A17
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Experimental Dermatology
JA  - Exp Dermatol
VL  - 24
IS  - 3
SN  - 0906-6705
UR  - https://doi.org/10.1111/exd.12623
DO  - doi:10.1111/exd.12623
SP  - E1
EP  - E50
PY  - 2015
ER  - 

TY  - JOUR
C7  - e12328
TI  - IXA 2017- Abstracts of the 14th Congress of the International Xenotransplantation Association, Baltimore, USA
JO  - Xenotransplantation
JA  - Xenotransplantation
VL  - 24
IS  - 5
SN  - 0908-665X
UR  - https://doi.org/10.1111/xen.12328
DO  - doi:10.1111/xen.12328
SP  - e12328
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - International Journal of Stroke
VL  - 7
IS  - s1
SN  - 1747-4930
UR  - https://doi.org/10.1111/j.1747-4930.2012.00907.x
DO  - doi:10.1111/j.1747-4930.2012.00907.x
SP  - 1
EP  - 69
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abtracts
JO  - Journal of Medical Primatology
JA  - J Med Primatol
VL  - 45
IS  - 5
SN  - 0047-2565
UR  - https://doi.org/10.1111/jmp.12245
DO  - doi:10.1111/jmp.12245
SP  - 222
EP  - 274
PY  - 2016
ER  - 

C7  - pp. 63-98
TI  - Nasal Disorders
SN  - 9781119482284
UR  - https://doi.org/10.1002/9781119482307.ch4
DO  - doi:10.1002/9781119482307.ch4
SP  - 63-98
KW  - aspergillus
KW  - brachycephalic obstructive airway syndrome
KW  - chronic rhinosinusitis
KW  - cryptococcosis
KW  - nasal neoplasia
KW  - nasal tumors
KW  - nasopharyngeal stenosis
PY  - 2016
AB  - Summary Brachycephalic obstructive airway syndrome is a congenital and heritable disorder of dogs and cats resulting from primary conformational defects of structures in the upper airway caused by severe shortening of muzzle. Nasopharyngeal stenosis is thought to occur either as a congenital lesion in which the caudal opening of the choanae is malformed, or as an acquired lesion resulting from chronic inflammation in the caudal aspect of the nasal cavity that forms a cicatrix. Cryptococcosis is an invasive fungus that exists in the yeast form in the animal. Aspergillus is a branching septate mold that is ubiquitous in the environment. Chronic Rhinosinusitis is one of the most common chronic upper respiratory tract disorders seen in the feline population and is characterized by nasal discharge and sneezing with excessive mucus production. Nasal tumors represent a small percentage of neoplasms in cats and dogs. Nasal neoplasia is primarily a disease of older dogs and cats.
ER  - 

TY  - JOUR
TI  - Abstracts from the 48th Annual Meeting of the European Society for Paediatric Research, Prague, Czech Republic
JO  - Acta Paediatrica
VL  - 96
IS  - s456
SN  - 9781119482284
UR  - https://doi.org/10.1111/j.1651-2227.2007.00463.x
DO  - doi:10.1111/j.1651-2227.2007.00463.x
SP  - 1
EP  - 245
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Session PTW08: Remyelination and differentiation
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781119482284
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_15.x
DO  - doi:10.1111/j.1474-1644.2005.03230_15.x
SP  - 109
EP  - 112
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PTW01: Receptors, transmitters, and channels
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781119482284
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_8.x
DO  - doi:10.1111/j.1474-1644.2005.03230_8.x
SP  - 81
EP  - 84
PY  - 2005
ER  - 

TY  - JOUR
AU  - Nave, Klaus
TI  - Plenary Talk P03: Axonâ€“glia interactions and the control of myelination
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781119482284
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_1.x
DO  - doi:10.1111/j.1474-1644.2005.03230_1.x
SP  - 69
EP  - 69
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PTW03: Glia and inflammation II
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781119482284
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_10.x
DO  - doi:10.1111/j.1474-1644.2005.03230_10.x
SP  - 88
EP  - 91
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PTW05: Ischemia
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781119482284
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_12.x
DO  - doi:10.1111/j.1474-1644.2005.03230_12.x
SP  - 95
EP  - 98
PY  - 2005
ER  - 

TY  - JOUR
AU  - Chandross, K.
AU  - Merrill, J.
TI  - Colloquium C11: Lipid pathways as targets for MS therapy
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781119482284
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_7.x
DO  - doi:10.1111/j.1474-1644.2005.03230_7.x
SP  - 79
EP  - 80
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PTW02: Gene expression and signaling II
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781119482284
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_9.x
DO  - doi:10.1111/j.1474-1644.2005.03230_9.x
SP  - 85
EP  - 87
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster session PTW06: Parkinson's and other diseases
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781119482284
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_13.x
DO  - doi:10.1111/j.1474-1644.2005.03230_13.x
SP  - 99
EP  - 103
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PTW07: Demyelination
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781119482284
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_14.x
DO  - doi:10.1111/j.1474-1644.2005.03230_14.x
SP  - 104
EP  - 108
PY  - 2005
ER  - 
